

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and managing... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-185/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-185" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and managing IgG4-related disease" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and managing IgG4-related disease.">
            <meta name="og:description" content="Read the latest article version by Anna R. Wolfson, Daniel L. Hamilos, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="10123">
            <meta name="article-id" content="9399">
            <meta name="dc.title" content="Recent advances in understanding and managing IgG4-related disease">
            <meta name="dc.description" content="IgG4-related disease was only recently discovered, so its description, management, and new discoveries related to its etiology are rapidly evolving. Because IgG4 itself is a unique antibody which is intimately related to the diagnosis of the disease, the role of plasmablasts in the pathophysiology remains an active area of discussion. Recent studies have uncovered a possible role for CD4-positive cytotoxic T lymphocytes, T follicular helper cells, and M2 macrophages. The clinical presentation is variable and can be vague, as this disease affects many organs and new presentations are continuing to be described. The diagnosis depends on clinical and histopathological assessment. The mainstay of treatment is with glucocorticoids, but rituximab has recently shown promise. Monitoring disease activity using imaging modalities (including positron emission tomography) and serum markers is imperative, as relapses are common. IgG4-related disease spans many medical disciplines but is a treatable condition with which all clinicians should be familiar.">
            <meta name="dc.subject" content="IgG4, plasmablasts, IgG4 related disease, IgG, Sjogren&rsquo;s syndrome, ">
            <meta name="dc.creator" content="Wolfson, Anna R.">
            <meta name="dc.creator" content="Hamilos, Daniel L.">
            <meta name="dc.date" content="2017/02/23">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.9399.1">
            <meta name="dc.source" content="F1000Research 2017 6:185">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="IgG4 ">
            <meta name="prism.keyword" content=" plasmablasts ">
            <meta name="prism.keyword" content=" IgG4 related disease ">
            <meta name="prism.keyword" content=" IgG ">
            <meta name="prism.keyword" content=" Sjogren&rsquo;s syndrome ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/02/23">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="185">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.9399.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-185">
            <meta name="citation_title" content="Recent advances in understanding and managing IgG4-related disease">
            <meta name="citation_abstract" content="IgG4-related disease was only recently discovered, so its description, management, and new discoveries related to its etiology are rapidly evolving. Because IgG4 itself is a unique antibody which is intimately related to the diagnosis of the disease, the role of plasmablasts in the pathophysiology remains an active area of discussion. Recent studies have uncovered a possible role for CD4-positive cytotoxic T lymphocytes, T follicular helper cells, and M2 macrophages. The clinical presentation is variable and can be vague, as this disease affects many organs and new presentations are continuing to be described. The diagnosis depends on clinical and histopathological assessment. The mainstay of treatment is with glucocorticoids, but rituximab has recently shown promise. Monitoring disease activity using imaging modalities (including positron emission tomography) and serum markers is imperative, as relapses are common. IgG4-related disease spans many medical disciplines but is a treatable condition with which all clinicians should be familiar.">
            <meta name="citation_description" content="IgG4-related disease was only recently discovered, so its description, management, and new discoveries related to its etiology are rapidly evolving. Because IgG4 itself is a unique antibody which is intimately related to the diagnosis of the disease, the role of plasmablasts in the pathophysiology remains an active area of discussion. Recent studies have uncovered a possible role for CD4-positive cytotoxic T lymphocytes, T follicular helper cells, and M2 macrophages. The clinical presentation is variable and can be vague, as this disease affects many organs and new presentations are continuing to be described. The diagnosis depends on clinical and histopathological assessment. The mainstay of treatment is with glucocorticoids, but rituximab has recently shown promise. Monitoring disease activity using imaging modalities (including positron emission tomography) and serum markers is imperative, as relapses are common. IgG4-related disease spans many medical disciplines but is a treatable condition with which all clinicians should be familiar.">
            <meta name="citation_keywords" content="IgG4, plasmablasts, IgG4 related disease, IgG, Sjogren&rsquo;s syndrome, ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Anna R. Wolfson">
            <meta name="citation_author_institution" content="Massachusetts General Hospital, Allergy and Immunology Division, Cox 201, 55 Fruit Street, Boston, Massachusetts, 02114, USA">
            <meta name="citation_author" content="Daniel L. Hamilos">
            <meta name="citation_author_institution" content="Massachusetts General Hospital, Allergy and Immunology Division, Cox 201, 55 Fruit Street, Boston, Massachusetts, 02114, USA">
            <meta name="citation_publication_date" content="2017/02/23">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="185">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.9399.1">
            <meta name="citation_firstpage" content="185">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-185/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-185.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=10123 /> <input type=hidden id=articleId name=articleId value=9399 /> <input type=hidden id=xmlUrl value="/articles/6-185/v1/xml"/> <input type=hidden id=xmlFileName value="-6-185-v1.xml"> <input type=hidden id=article_uuid value=ef29d428-3655-46c9-8aab-e7ae66c36d01 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and managing IgG4-related disease"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.9399.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.9399.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-185"
  },
  "headline": "Recent advances in understanding and managing IgG4-related disease",
  "datePublished": "2017-02-23T16:26:43",
  "dateModified": "2017-02-23T16:26:43",
  "author": [
    {
      "@type": "Person",
      "name": "Anna R. Wolfson"
    },    {
      "@type": "Person",
      "name": "Daniel L. Hamilos"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "IgG4-related disease was only recently discovered, so its description, management, and new discoveries related to its etiology are rapidly evolving. Because IgG4 itself is a unique antibody which is intimately related to the diagnosis of the disease, the role of plasmablasts in the pathophysiology remains an active area of discussion. Recent studies have uncovered a possible role for CD4-positive cytotoxic T lymphocytes, T follicular helper cells, and M2 macrophages. The clinical presentation is variable and can be vague, as this disease affects many organs and new presentations are continuing to be described. The diagnosis depends on clinical and histopathological assessment. The mainstay of treatment is with glucocorticoids, but rituximab has recently shown promise. Monitoring disease activity using imaging modalities (including positron emission tomography) and serum markers is imperative, as relapses are common. IgG4-related disease spans many medical disciplines but is a treatable condition with which all clinicians should be familiar."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-185",
            "name": "Recent advances in understanding and managing IgG4-related disease"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and managing IgG4-related disease </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=10123 data-id=9399 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9399.1" data-recommended="" data-doi="10.12688/f1000research.9399.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-185/v1/pdf?article_uuid=ef29d428-3655-46c9-8aab-e7ae66c36d01" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-9399-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-9399-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-9399-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Wolfson AR and Hamilos DL. Recent advances in understanding and managing IgG4-related disease [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):185 (<a class=new-orange href="https://doi.org/10.12688/f1000research.9399.1" target=_blank>https://doi.org/10.12688/f1000research.9399.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-9399-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=9399 id=track-article-signin-9399 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9399?target=/articles/6-185">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10123 /> <input name=articleId type=hidden value=9399 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and managing IgG4-related disease</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:awolfson@partners.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Anna R. Wolfson</span></a>,&nbsp;</span><span class="">Daniel L. Hamilos</span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:awolfson@partners.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Anna R. Wolfson</span></a>,&nbsp;</span><span class="">Daniel L. Hamilos</span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 23 Feb 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.9399.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Massachusetts General Hospital, Allergy and Immunology Division, Cox 201, 55 Fruit Street, Boston, Massachusetts, 02114, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=20016-19680></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=20019-19683></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=20018-19682></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=20017-19681></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> IgG4-related disease was only recently discovered, so its description, management, and new discoveries related to its etiology are rapidly evolving. Because IgG4 itself is a unique antibody which is intimately related to the diagnosis of the disease, the role of plasmablasts in the pathophysiology remains an active area of discussion. Recent studies have uncovered a possible role for CD4-positive cytotoxic T lymphocytes, T follicular helper cells, and M2 macrophages. The clinical presentation is variable and can be vague, as this disease affects many organs and new presentations are continuing to be described. The diagnosis depends on clinical and histopathological assessment. The mainstay of treatment is with glucocorticoids, but rituximab has recently shown promise. Monitoring disease activity using imaging modalities (including positron emission tomography) and serum markers is imperative, as relapses are common. IgG4-related disease spans many medical disciplines but is a treatable condition with which all clinicians should be familiar. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> IgG4, plasmablasts, IgG4 related disease, IgG, Sjogren’s syndrome, </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Anna R. Wolfson (<a href="mailto:awolfson@partners.org">awolfson@partners.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Anna R. Wolfson </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Wolfson AR and Hamilos DL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Wolfson AR and Hamilos DL. Recent advances in understanding and managing IgG4-related disease [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):185 (<a href="https://doi.org/10.12688/f1000research.9399.1" target=_blank>https://doi.org/10.12688/f1000research.9399.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 23 Feb 2017, <b>6</b>(F1000 Faculty Rev):185 (<a href="https://doi.org/10.12688/f1000research.9399.1" target=_blank>https://doi.org/10.12688/f1000research.9399.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 23 Feb 2017, <b>6</b>(F1000 Faculty Rev):185 (<a href="https://doi.org/10.12688/f1000research.9399.1" target=_blank>https://doi.org/10.12688/f1000research.9399.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e143>Introduction</h2><p class="" id=d21037e146>IgG4-related disease is a recently described entity which is quite rare. Descriptions and recognition of the disease are advancing rapidly. Certainly, the fact that it closely resembles malignancy is one of the many reasons why recognizing this disease is important. Furthermore, it is generally very treatment-responsive, so early diagnosis can contribute to a significant improvement in morbidity for patients. The underlying disease mechanisms are an area of active research, and further understanding will aid in the treatment of patients.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e152>Epidemiology</h2><p class="" id=d21037e155>Because IgG4-related disease was only recently described and mimics other diseases, recognition remains low and a true estimation of prevalence remains elusive. In 2011, the prevalence of autoimmune pancreatitis in Japan was 4.6 per 100,000 population<sup><a href="#ref-1">1</a></sup>, but prevalence data for other organs involved in IgG4-related disease are not well characterized. In Japanese patients with autoimmune pancreatitis as well as Japanese patients with IgG4-related disease of other organ types<sup><a href="#ref-2">2</a></sup>, the patients are predominantly male; there are 3 to 4 males to every 1 female patient. The mean age in both studies was late 60s. In a cohort from Spain with IgG4-related disease, 69.1% of patients were male and the median age at diagnosis was 53 years<sup><a href="#ref-3">3</a></sup>.</p><p class="" id=d21037e170>Interestingly, a recent review analyzed published pediatric cases of IgG4-related disease and found 25 cases with an average age of 13 and a mild female predominance (64%)<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d21037e177>In one small cohort of 25 patients with IgG4-associated cholangitis and autoimmune pancreatitis, 88% reported a history of “blue collar” work, often with exposures to occupational chemicals<sup><a href="#ref-5">5</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e187>Clinical presentation</h2><p class="" id=d21037e190>Patients classically present with subacute, non-specific complaints, which can be general, such as weight loss, or organ-specific complaints. The classic finding is a tumefactive lesion in at least one organ, but the disease can develop over years, adding new organs one at a time, so patients may present with multi-organ disease<sup><a href="#ref-6">6</a></sup>. In the study by Chen <i>et al</i>., the mean number of organs involved was 3.0 ± 1.6 (range of 1–10)<sup><a href="#ref-7">7</a></sup>. If the disease has progressed, organ failure can occur. Ruling out malignancy is crucial when the diagnosis of IgG4-related disease is considered. The differential is broad and is largely organ-specific, but multi-centric Castleman’s disease and other multi-organ autoimmune diseases such as granulomatosis with polyangiitis, Sjögren’s syndrome, eosinophilic granulomatosis with polyangiitis, and sarcoidosis should be considered.</p><p class="" id=d21037e204>Although the classic organ involved in IgG4-related disease is the pancreas, which presents classically with obstructive jaundice due to damage to the biliary tree, many organs can be involved (<a href="#f1">Figure 1</a>). Recent novel reports of IgG4-related disease include disease involving the lung presenting with cough, dyspnea, chest pain, and fever<sup><a href="#ref-8">8</a></sup>; involving the sinuses, which in some cases can be invasive<sup><a href="#ref-9">9</a>–<a href="#ref-11">11</a></sup>; involving the esophagus presenting with dysphagia<sup><a href="#ref-12">12</a></sup>; involving the prostate presenting with urinary retention<sup><a href="#ref-13">13</a></sup>; or involving the testes presenting with scrotal pain<sup><a href="#ref-14">14</a></sup>. Skin manifestations were rare in the series reported by Chen <i>et al</i>.<sup><a href="#ref-7">7</a></sup>. A review of the dermatological literature showed that the most common skin presentations are papules, plaques, and nodules of the head and neck<sup><a href="#ref-15">15</a></sup>. Clinical symptoms of patients were well summarized by Chen <i>et al</i>. (<a href="#T1">Table 1</a>)<sup><a href="#ref-7">7</a></sup>. Organ involvement from three case series is summarized in <a href="#T2">Table 2</a>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/10123/c9f51dd9-75a2-4083-acfd-b3bb29f63a1f_figure1.gif"><img alt="c9f51dd9-75a2-4083-acfd-b3bb29f63a1f_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/10123/c9f51dd9-75a2-4083-acfd-b3bb29f63a1f_figure1.gif"></a><div class=caption><h3>Figure 1. Many organs are involved in IgG4-related disease.</h3><p id=d21037e269>This figure shows diseases that have now been re-classified to be part of IgG4-related disease, including eponymous names.</p></div></div><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Clinical manifestations of IgG4-related disease, as summarized in Chen <i>et al</i>. (out of 200 cases, 91% Chinese)<sup><a href="#ref-7">7</a></sup>.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21037e294 class=n-a></a><thead><a name=d21037e296 class=n-a></a><tr><a name=d21037e298 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d21037e300 class=n-a></a>Clinical sign or symptom</th><th align=left colspan=1 rowspan=1 valign=top><a name=d21037e303 class=n-a></a>Percentage reporting<br class=br>sign or symptom in<br class=br>Chen <i>et al</i>.<sup><a href="#ref-7">7</a></sup></th></tr></thead><tbody><a name=d21037e318 class=n-a></a><tr><a name=d21037e320 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e322 class=n-a></a>Submandibular gland swelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e325 class=n-a></a>51.0%</td></tr><tr><a name=d21037e329 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e331 class=n-a></a>Lacrimal gland swelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e334 class=n-a></a>42.0%</td></tr><tr><a name=d21037e338 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e340 class=n-a></a>Superficial lymph node enlargement</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e343 class=n-a></a>37.0%</td></tr><tr><a name=d21037e347 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e349 class=n-a></a>Abdominal pain</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e352 class=n-a></a>35.0%</td></tr><tr><a name=d21037e356 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e358 class=n-a></a>Parotid gland swelling</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e361 class=n-a></a>24.0%</td></tr><tr><a name=d21037e366 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e368 class=n-a></a>Nasal congestion</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e371 class=n-a></a>21.5%</td></tr><tr><a name=d21037e375 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e377 class=n-a></a>Jaundice</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e380 class=n-a></a>14.0%</td></tr><tr><a name=d21037e384 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e386 class=n-a></a>Pruritus</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e389 class=n-a></a>13.5%</td></tr><tr><a name=d21037e393 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e395 class=n-a></a>Cough</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e398 class=n-a></a>13.5%</td></tr><tr><a name=d21037e402 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e404 class=n-a></a>Lower back pain</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e407 class=n-a></a>13.5%</td></tr><tr><a name=d21037e411 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e413 class=n-a></a>Dysuresia</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e416 class=n-a></a>13.0%</td></tr><tr><a name=d21037e421 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e423 class=n-a></a>Dry mouth/dry eye</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e426 class=n-a></a>12.5%</td></tr><tr><a name=d21037e430 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e432 class=n-a></a>Nausea or vomiting or both</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e435 class=n-a></a>12.0%</td></tr><tr><a name=d21037e439 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e441 class=n-a></a>Fever</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e444 class=n-a></a>9.0%</td></tr><tr><a name=d21037e448 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e450 class=n-a></a>Edema</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e453 class=n-a></a>8.5%</td></tr><tr><a name=d21037e457 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e459 class=n-a></a>Exophthalmos</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e462 class=n-a></a>5.5%</td></tr><tr><a name=d21037e466 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e468 class=n-a></a>Arthralgia</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e471 class=n-a></a>4.0%</td></tr><tr><a name=d21037e476 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e478 class=n-a></a>Thyroid enlargement</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e481 class=n-a></a>2.5%</td></tr><tr><a name=d21037e485 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e487 class=n-a></a>History of allergy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e490 class=n-a></a>59.0%</td></tr><tr><a name=d21037e494 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e496 class=n-a></a>Asymptomatic</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e499 class=n-a></a>1.0%</td></tr></tbody></table></div><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Comparison of organ involvement in three large case series.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21037e518 class=n-a></a><thead><a name=d21037e520 class=n-a></a><tr><a name=d21037e522 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d21037e524 class=n-a></a>Organ</th><th align=left colspan=1 rowspan=1 valign=top><a name=d21037e527 class=n-a></a>Chen <i>et al</i>.<sup><a href="#ref-7">7</a></sup>,<br class=br>percentage<br class=br>of 200 cases<sup><a href="#note-1">a</a></sup></th><th align=left colspan=1 rowspan=1 valign=top><a name=d21037e544 class=n-a></a>Fernandez-<br class=br>Codina <i>et al</i>.<sup><a href="#ref-3">3</a></sup>,<br class=br>percentage of<br class=br>55 cases<sup><a href="#note-1">b</a></sup></th><th align=left colspan=1 rowspan=1 valign=top><a name=d21037e564 class=n-a></a>Inoue <i>et al</i>.<sup><a href="#ref-2">2</a></sup>,<br class=br>percentage<br class=br>of 235<br class=br>cases<sup><a href="#note-1">c</a></sup></th></tr></thead><tbody><a name=d21037e586 class=n-a></a><tr><a name=d21037e588 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e590 class=n-a></a>Lymph nodes</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e593 class=n-a></a>56.5%</td><td align=left colspan=1 rowspan=1><a name=d21037e596 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d21037e598 class=n-a></a></td></tr><tr><a name=d21037e601 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e603 class=n-a></a>Adenopathic</td><td align=left colspan=1 rowspan=1><a name=d21037e606 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e608 class=n-a></a>2%</td><td align=left colspan=1 rowspan=1><a name=d21037e611 class=n-a></a></td></tr><tr><a name=d21037e614 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e616 class=n-a></a>Salivary glands</td><td align=left colspan=1 rowspan=1><a name=d21037e619 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e621 class=n-a></a>16%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e624 class=n-a></a>34%</td></tr><tr><a name=d21037e628 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e630 class=n-a></a>Submandibular<br class=br>gland</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e635 class=n-a></a>51.0%</td><td align=left colspan=1 rowspan=1><a name=d21037e638 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d21037e640 class=n-a></a></td></tr><tr><a name=d21037e643 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e645 class=n-a></a>Parotid gland</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e648 class=n-a></a>24.0%</td><td align=left colspan=1 rowspan=1><a name=d21037e651 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d21037e653 class=n-a></a></td></tr><tr><a name=d21037e657 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e659 class=n-a></a>Pancreas</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e662 class=n-a></a>38.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e665 class=n-a></a>16%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e668 class=n-a></a>60%<sup><a href="#note-1">c</a></sup></td></tr><tr><a name=d21037e675 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e677 class=n-a></a>Lung</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e680 class=n-a></a>32.0%<sup><a href="#note-1">d</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e686 class=n-a></a>9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e689 class=n-a></a>13%</td></tr><tr><a name=d21037e693 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e695 class=n-a></a>Pleura</td><td align=left colspan=1 rowspan=1><a name=d21037e698 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e700 class=n-a></a>4%</td><td align=left colspan=1 rowspan=1><a name=d21037e703 class=n-a></a></td></tr><tr><a name=d21037e706 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e708 class=n-a></a>Sinus</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e711 class=n-a></a>21.5%</td><td align=left colspan=1 rowspan=1><a name=d21037e714 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d21037e716 class=n-a></a></td></tr><tr><a name=d21037e719 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e721 class=n-a></a>Maxillary</td><td align=left colspan=1 rowspan=1><a name=d21037e724 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e726 class=n-a></a>15%</td><td align=left colspan=1 rowspan=1><a name=d21037e729 class=n-a></a></td></tr><tr><a name=d21037e732 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e734 class=n-a></a>Bile ducts/biliary</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e737 class=n-a></a>19.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e740 class=n-a></a>4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e743 class=n-a></a>13%</td></tr><tr><a name=d21037e748 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e750 class=n-a></a>Retroperitoneal<br class=br>tissue</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e755 class=n-a></a>18.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e758 class=n-a></a>27%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e761 class=n-a></a>4%</td></tr><tr><a name=d21037e765 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e767 class=n-a></a>Prostate</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e770 class=n-a></a>13.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e773 class=n-a></a>0%</td><td align=left colspan=1 rowspan=1><a name=d21037e776 class=n-a></a></td></tr><tr><a name=d21037e779 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e781 class=n-a></a>Kidney</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e784 class=n-a></a>10.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e787 class=n-a></a>7%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e790 class=n-a></a>23%</td></tr><tr><a name=d21037e794 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e796 class=n-a></a>Artery</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e799 class=n-a></a>7.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e802 class=n-a></a>0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e805 class=n-a></a>4%</td></tr><tr><a name=d21037e809 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e811 class=n-a></a>Gallbladder</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e814 class=n-a></a>5.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e817 class=n-a></a>5%</td><td align=left colspan=1 rowspan=1><a name=d21037e820 class=n-a></a></td></tr><tr><a name=d21037e823 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e825 class=n-a></a>Skin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e828 class=n-a></a>5.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e831 class=n-a></a>0%</td><td align=left colspan=1 rowspan=1><a name=d21037e834 class=n-a></a></td></tr><tr><a name=d21037e838 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e840 class=n-a></a>Inflammatory<br class=br>pseudotumor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e845 class=n-a></a>5.0%</td><td align=left colspan=1 rowspan=1><a name=d21037e848 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d21037e850 class=n-a></a></td></tr><tr><a name=d21037e853 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e855 class=n-a></a>Liver</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e858 class=n-a></a>3.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e861 class=n-a></a>0%</td><td align=left colspan=1 rowspan=1><a name=d21037e864 class=n-a></a></td></tr><tr><a name=d21037e867 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e869 class=n-a></a>Orbit</td><td align=left colspan=1 rowspan=1><a name=d21037e872 class=n-a></a></td><td align=left colspan=1 rowspan=1><a name=d21037e874 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e876 class=n-a></a>4%</td></tr><tr><a name=d21037e880 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e882 class=n-a></a>Orbitary<br class=br>pseudotumor</td><td align=left colspan=1 rowspan=1><a name=d21037e887 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e889 class=n-a></a>22%</td><td align=left colspan=1 rowspan=1><a name=d21037e892 class=n-a></a></td></tr><tr><a name=d21037e895 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e897 class=n-a></a>Extraocular<br class=br>muscles</td><td align=left colspan=1 rowspan=1><a name=d21037e902 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e904 class=n-a></a>2%</td><td align=left colspan=1 rowspan=1><a name=d21037e907 class=n-a></a></td></tr><tr><a name=d21037e910 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e912 class=n-a></a>Lacrimal gland</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e915 class=n-a></a>42.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e918 class=n-a></a>15%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e921 class=n-a></a>23%</td></tr><tr><a name=d21037e926 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e928 class=n-a></a>Aorta</td><td align=left colspan=1 rowspan=1><a name=d21037e931 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e933 class=n-a></a>9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e936 class=n-a></a>20%</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=note-1 class=n-a></a><p id=d21037e946> Chen <i>et al</i>. had predominantly Chinese cases<sup><a href="#ref-7">7</a></sup>, Fernandez-Codina <i>et al</i>.<sup><a href="#ref-3">3</a></sup> analyzed patients from a Spanish registry<sup><a href="#ref-6">6</a></sup>, and Inoue <i>et al</i>. studied a Japanese cohort<sup><a href="#ref-2">2</a></sup>. <sup>a</sup>Chen <i>et al</i>. included those who fulfilled 2011 diagnostic criteria for definite, probable, or possible IgG4-related disease<sup><a href="#ref-7">7</a></sup>. <sup>b</sup>Fernandez-Codina <i>et al</i>. used 2012 international diagnostic consensus on IgG4-related disease for their inclusion<sup><a href="#ref-6">6</a></sup>. Fernandez-Codina <i>et al</i>. also reported 2% involvement of the thyroid, breast, pericardium, or mediastinum; 7% involvement of the mesentery; 4% involvement of the pachymeninges; and 0% involvement of the hypophysis. <sup>c</sup>Inoue <i>et al</i>. included patients with a diagnosis of type I autoimmune pancreatitis as well as those with IgG4-related disease on pathology, which is possibly what accounts for a greater number of patients with pancreatic involvement<sup><a href="#ref-2">2</a></sup>. Inoue <i>et al</i>. reported 5% involvement of the paravertebra and 3% other sites. <sup>d</sup>In Chen <i>et al</i>., this includes parenchyma, airway, and pleura.</p></div></div></div><p class="" id=d21037e1022>Although most patients present before multi-organ involvement is evident, Higashioka <i>et al</i>. reported a case of a patient who had 10 organs involved in IgG4-related disease at the time of his diagnosis<sup><a href="#ref-16">16</a></sup>.</p><p class="" id=d21037e1032>The clinical presentation of IgG4-related disease often mimics a tumor, which can result in unnecessary surgical intervention. Surgical resection for presumed malignancies occurred in 18 out of 53 patients, about 34%, who were ultimately diagnosed with IgG4-associated cholangitis in the series reported by Ghazale <i>et al</i>.<sup><a href="#ref-17">17</a></sup>. For example, Park and Kim<sup><a href="#ref-18">18</a></sup> and Wang <i>et al</i>.<sup><a href="#ref-19">19</a></sup> reported a case in which the discovery of a mass in the renal parenchyma resulted in a patient undergoing nephrectomy, and ultimately the mass was found to be IgG4-related disease. Similarly, Kim <i>et al</i>. presented a case of a patient in whom there was concern for cholangiocarcinoma and who underwent a left trisectionectomy but was ultimately diagnosed with IgG4-related disease<sup><a href="#ref-20">20</a></sup>. IgG4-related disease can also be initially mistaken for lymphoma, as both diseases can present with lymph node swelling as an initial symptom<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>. Differentiating IgG4-related disease from cancer is of the utmost importance. The diagnosis of IgG4-related disease is ultimately reliant on diagnostic tools (<a href="#T3">Table 3</a>).</p><div class="table-wrap panel clearfix"><a name=T3 class=n-a></a><div class=caption><h3>Table 3. Evolution of diagnostic criteria for diagnosis of IgG4-related disease.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21037e1082 class=n-a></a><tbody><a name=d21037e1084 class=n-a></a><tr><a name=d21037e1086 class=n-a></a><td align=left colspan=1 rowspan=6 valign=top><a name=d21037e1088 class=n-a></a><b>Autoimmune pancreatitis diagnosis</b><br class=br><b>using the HISORt<sup><a href="#note-2">a</a></sup> criteria, 2007<sup><a href="#ref-73">73</a></sup></b></td><td align=left colspan=2 rowspan=1><a name=d21037e1102 class=n-a></a>Obstructive jaundice, pancreatic mass/enlargement, or pancreatitis with<br class=br>at least one of the HISORt criteria:</td></tr><tr><a name=d21037e1108 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1110 class=n-a></a>Histology</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1113 class=n-a></a>Lymphoplasmacytic infiltrate with storiform fibrosis or<br class=br>immunostaining shows abundant IgG4-positive cells.</td></tr><tr><a name=d21037e1119 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1121 class=n-a></a>Imaging</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1124 class=n-a></a>Diffusely enlarged pancreas and a diffusely irregular,<br class=br>narrow pancreatic duct</td></tr><tr><a name=d21037e1130 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1132 class=n-a></a>Serology</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1135 class=n-a></a>Elevated IgG4 levels</td></tr><tr><a name=d21037e1139 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1141 class=n-a></a>Other organ<br class=br>involvement</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1146 class=n-a></a>Extrapancreatic manifestations</td></tr><tr><a name=d21037e1151 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1153 class=n-a></a>Response to<br class=br>therapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1158 class=n-a></a>Manifestations resolve with steroid therapy</td></tr><tr><a name=d21037e1162 class=n-a></a><td align=left colspan=1 rowspan=6 valign=top><a name=d21037e1164 class=n-a></a><b>IgG4-associated cholangitis diagnosis</b><br class=br><b>using the HISORt criteria, 2008<sup><a href="#ref-17">17</a></sup></b></td></tr><tr><a name=d21037e1175 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1177 class=n-a></a>Histology of bile<br class=br>duct</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1182 class=n-a></a>Lymphoplasmacytic sclerosing cholangitis on<br class=br>resection specimens</td></tr><tr><a name=d21037e1188 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1190 class=n-a></a>Imaging</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1193 class=n-a></a>Strictures of the bile ducts</td></tr><tr><a name=d21037e1197 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1199 class=n-a></a>Serology</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1202 class=n-a></a>Elevated IgG4 levels</td></tr><tr><a name=d21037e1206 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1208 class=n-a></a>Other organ<br class=br>involvement</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1213 class=n-a></a>Pancreas, kidney, retroperitoneum, salivary glands</td></tr><tr><a name=d21037e1218 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1220 class=n-a></a>Response to<br class=br>therapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21037e1225 class=n-a></a>Normalization of liver enzyme levels or resolution of<br class=br>stricture</td></tr><tr><a name=d21037e1231 class=n-a></a><td align=left colspan=1 rowspan=5 valign=top><a name=d21037e1233 class=n-a></a><b>Comprehensive diagnostic criteria for</b><br class=br><b>IgG4-related disease, 2011<sup><a href="#ref-74">74</a></sup></b></td></tr><tr><a name=d21037e1244 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d21037e1246 class=n-a></a>Definite: 1+2+3. Probable: 1+3. Possible: 1+2.</td></tr><tr><a name=d21037e1250 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d21037e1252 class=n-a></a>1. Clinical examination showing characteristic diffuse/localized swelling or<br class=br>masses in single or multiple organs</td></tr><tr><a name=d21037e1258 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d21037e1260 class=n-a></a>2. Hematological examination shows elevated serum IgG4 concentrations<br class=br>(135 mg/dL)</td></tr><tr><a name=d21037e1266 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d21037e1268 class=n-a></a>3. Histopathologic examination shows<br class=br>(1) Marked lymphocyte and plasmacyte infiltration and fibrosis<br class=br>(2) Infiltration of IgG4<sup>+</sup> plasma cells: ratio of IgG4<sup>+</sup> to IgG<sup>+</sup> cells &gt;40% and<br class=br>&gt;10 IgG4<sup>+</sup> plasma cells per high-power field</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=note-2 class=n-a></a><p id=d21037e1297> In 2007, Chari published criteria to diagnose autoimmune pacreatitis<sup><a href="#ref-73">73</a></sup>, and Ghazale <i>et al</i>. followed in 2008 with criteria to diagnose IgG4-associated cholangitis<sup><a href="#ref-17">17</a></sup>; both were the Mayo Clinic experiences. Ultimately, in 2011, comprehensive criteria for diagnosing IgG4-related disease were developed by Umehara <i>et al</i>., from Japan<sup><a href="#ref-74">74</a></sup>. <sup>a</sup>HISORt, histology, imaging, serology, other organ involvement, and response to therapy.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1328>Monitoring and following disease</h2><div class=section><a name=d21037e1331 class=n-a></a><h3 class=section-title>Serum studies</h3><p class="" id=d21037e1336>Although IgG4 levels are classically elevated in IgG4-related disease (Japanese criterion is more than 135 mg/dL), this finding is not necessary to make the diagnosis—which is based on histopathological findings when histopathology is available, as obtaining specimens (for example, in the pancreas and biliary tract) is not without risk—and is not specific to the disease<sup><a href="#ref-23">23</a></sup>. Indeed, approximately 30% of patients with IgG4-related disease have normal IgG4 serum levels<sup><a href="#ref-23">23</a></sup> (the upper limit of normal for serum IgG4 is 135 mg/dL<sup><a href="#ref-6">6</a></sup>), but the greater the number of organs involved in the disease, the higher the elevation in the serum IgG4 level<sup><a href="#ref-24">24</a></sup>. An elevated IgG4 level is also not specific for the disease, as there are many diseases associated with this laboratory abnormality; it similarly does not have a good positive predictive value<sup><a href="#ref-25">25</a></sup>. Importantly, Oseini <i>et al</i>. showed that elevated IgG4 can be seen in patients with cholangiocarcinoma<sup><a href="#ref-24">24</a></sup>, and Ghazale <i>et al</i>. showed that elevated IgG4 cannot be used to distinguish autoimmune pancreatitis from pancreatic cancer, thus elevated serum IgG4 levels do not exclude these deadly differential diagnoses<sup><a href="#ref-26">26</a></sup>. Patients with primary sclerosing cholangitis can also have elevated IgG4 levels<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. However, 65 out of 72 patients with IgG4-related disease had elevated IgG4 levels, yielding a sensitivity of 90% according to a study by Carruthers <i>et al</i>.<sup><a href="#ref-25">25</a></sup>.</p><p class="" id=d21037e1389>With glucocorticoid treatment, elevated IgG4 levels can decrease but may remain above the upper limit of normal<sup><a href="#ref-23">23</a></sup>. In one study of the treatment of autoimmune pancreatitis, the IgG4 level remained above the upper limit of normal in 115 out of 182 patients (63%) treated with glucocorticoids<sup><a href="#ref-29">29</a></sup>. Furthermore, despite elevated levels, patients may remain in remission; in this study, only 30% of patients with persistent elevation of serum IgG4 had a relapse<sup><a href="#ref-29">29</a></sup>. Although an increase in IgG4 level may be a marker of relapse in some patients, for 10% of the patients in this study, relapses also occurred without an increase in the serum concentration of IgG4<sup><a href="#ref-29">29</a></sup>.</p><p class="" id=d21037e1408>Although it is not yet clinically available, quantitation of circulating plasmablasts using flow cytometry is more sensitive than serum IgG4 levels, so this measurement could emerge as a better test for the diagnosis and monitoring of IgG4-related disease in the future<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>.</p><p class="" id=d21037e1418>IgG4/IgG RNA ratio is a novel, highly accurate marker for IgG4-related disease and has been validated for IgG4-associated cholangitis and autoimmune pancreatitis<sup><a href="#ref-32">32</a></sup>. The clinician should be aware that very high serum IgG4 levels may lead to errors in the measurement of IgG4 serum concentrations, resulting in reporting of spuriously low values, a type of “prozone” effect<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d21037e1430>In conclusion, IgG4 levels alone are insufficient to make a diagnosis of IgG4-related disease or to monitor patients in follow-up. Elevations in eosinophils and C-reactive protein can also be observed in patients with IgG4-related disease, but these are non-specific<sup><a href="#ref-6">6</a></sup>.</p></div><div class=section><a name=d21037e1438 class=n-a></a><h3 class=section-title>Imaging</h3><p class="" id=d21037e1443>As already stated, histopathology is an integral part of the diagnosis, but imaging can aid in defining the disease involvement and in follow-up. A recent study showed the efficacy of using positron emission tomography/computed tomography (PET/CT) with the glucose analogue 2-[(18)F]-fluoro-2-deoxy-d-glucose (FDG) in patients diagnosed with one-organ involvement of IgG4-related disease to assess for the involvement of other organs<sup><a href="#ref-34">34</a></sup>. In this study, Zhang <i>et al</i>. reported that 9 out of 10 patients initially enrolled in the study with single-organ disease were ultimately found to have multi-organ disease<sup><a href="#ref-34">34</a></sup>. PET/CT is also useful for monitoring disease progression and identifying sites for biopsy<sup><a href="#ref-35">35</a></sup>. CT and magnetic resonance imaging (MRI) can also be used to identify organ enlargement, and lesions identified by CT typically generate low signal intensity in T2-weighted MRI<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1472>Histopathology of IgG4-related disease</h2><p class="" id=d21037e1475>Histopathology is the gold standard for diagnosis of IgG4-related disease, since the disease cannot be diagnosed on the basis of IgG4 levels in the serum or in tissue samples on pathology, although these findings are suggestive of the disease. The classic findings are dense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis (which means partial or complete obliteration of a vein)<sup><a href="#ref-38">38</a></sup>.<b></b>The presence of at least two of these findings in combination with infiltration of IgG4-positive plasma cells is highly suggestive of a diagnosis of IgG4-related disease, with the cutoff value for the number of IgG4-positive plasma cells being defined for each organ. Eosinophils are commonly present. IgG4-positive plasma cells are distributed diffusely throughout the tissue, even in patients who have normal levels of serum IgG4. This finding can help to differentiate IgG4-related disease from other diseases characterized by plasma cell infiltration but is not sufficient to make the diagnosis. The cutoff value for the number of IgG4-positive plasma cells required to make a diagnosis is specific to the organ, but the ratio of IgG4 to IgG cells must be greater than 40%<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d21037e1488>It is worth mentioning that the clinician must be cautious to not over-emphasize the role of histopathology, especially IgG4 immunostaining, when making a diagnosis of IgG4-related disease. Strehl <i>et al</i>. highlighted this nicely: they analyzed 121 randomly selected pathology specimens with lymphoplasmacytic infiltrates<sup><a href="#ref-39">39</a></sup>. Interestingly, variably high numbers of IgG4-positive plasma cells were found in diverse samples, particularly in rheumatoid synovitis, carcinoma-associated inflammation, and sclerosing sialadenitis<sup><a href="#ref-39">39</a></sup>. This article thus highlights the fact that IgG4 can be elevated in inflammation unrelated to IgG4-related disease<sup><a href="#ref-39">39</a></sup>. Cheuk and Chan also warned of the danger of over-interpretation of lymphadenopathy with positive immunostaining for IgG4 in a patient with no other clinical or laboratory signs of IgG4-related disease<sup><a href="#ref-40">40</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1514>Treatment options</h2><div class=section><a name=d21037e1517 class=n-a></a><h3 class=section-title>Watchful waiting</h3><p class="" id=d21037e1522>Although organ involvement in IgG4-related disease requires treatment, less aggressive management is appropriate if this is not the case. For example, in asymptomatic lymphadenopathy, watchful waiting is acceptable.</p></div><div class=section><a name=d21037e1526 class=n-a></a><h3 class=section-title>Glucocorticoids</h3><p class="" id=d21037e1531>The first-line treatment of IgG4-related disease is glucocorticoids<sup><a href="#ref-29">29</a></sup>, and the first prospective, randomized, placebo-controlled trial examining their efficacy for the treatment of autoimmune pancreatitis was just published by Masamune <i>et al</i>.<sup><a href="#ref-41">41</a></sup>. In this study, remission was induced with prednisolone in both groups and then withdrawn at 26 weeks in 19 of the patients versus continued for 3 years in 30 patients<sup><a href="#ref-41">41</a></sup>. The authors found that the relapse rate was significantly lower in the maintenance group, where 7 out of 30 patients (23.3%) relapsed compared with the cessation group, where 11 out of 19 (57.9%) relapsed (<i>P</i> = 0.011)<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d21037e1557>The initial treatment for autoimmune pancreatitis is typically prednisolone 0.6 mg/kg for 2 to 4 weeks, which is then tapered every 2 to 4 weeks to 5 mg/day over the subsequent 3 to 6 months, and then 2.5 to 5 mg/day is continued for 3 years<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>. Notably, low doses of prednisone may be as effective as higher doses for induction therapy: a retrospective review found that outcomes were not significantly different in patients who received prednisone in the range of 10 to 60 mg per day<sup><a href="#ref-44">44</a></sup>. Clinical symptoms, imaging, and blood tests are used to guide the taper<sup><a href="#ref-42">42</a></sup>. Many patients have an effective, rapid response to glucocorticoids, and an alternative diagnosis should be considered if this rapid response is not seen<sup><a href="#ref-42">42</a>,<a href="#ref-45">45</a></sup>. Advanced fibrosis, however, is a poor prognostic sign<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d21037e1586>A recent systematic review by Brito-Zeron <i>et al</i>. reflects the common paradigm with treatment with glucocorticoids: 1,186 out of 1,220 patients (97%) who received monotherapy with glucocorticoids as their first-line drug had a therapeutic response, but the response was classified as complete in only 84 out of 130 patients (65%) in whom this information could be extracted<sup><a href="#ref-45">45</a></sup>. This study also discussed the management of relapses, where glucocorticoids were most commonly used but immunosuppressive agents were used in 149 cases (39%) (azathioprine in 126 out of these 149 cases) and rituximab in 9 cases (2%)<sup><a href="#ref-45">45</a></sup>. The treatment was reported to be effective to treat the relapses for 219 out of 231 cases (95%) treated with glucocorticoids, 56 out of 69 patients (81%) treated with azathioprine, 16 out of 22 patients (72%) treated with other immunosuppressives, and 9 out of 9 patients (100%) treated with rituximab<sup><a href="#ref-45">45</a></sup>.</p></div><div class=section><a name=d21037e1605 class=n-a></a><h3 class=section-title>Alternatives to glucocorticoids</h3><p class="" id=d21037e1610>Steroid-sparing treatments, such as azathioprine, mycophenolate mofetil, and methotrexate, are used to allow respite from the side effects of glucocorticoids and in order to maintain remission, but evidence for their effectiveness is lacking<sup><a href="#ref-42">42</a></sup>. A more recent, promising option is treatment with rituximab; the mechanism is via the depletion of CD20-positive plasmablast precursors— with fewer plasmablasts, IgG4 production decreases<sup><a href="#ref-46">46</a></sup>. Yamamoto <i>et al</i>. recently published a case report of successful treatment with abatacept (an inhibitor of T-cell activation), but treatment with this is in its infancy<sup><a href="#ref-47">47</a></sup>.</p></div><div class=section><a name=d21037e1629 class=n-a></a><h3 class=section-title>Alternatives to medication</h3><p class="" id=d21037e1634>Surgery and radiotherapy have been reported to treat tumefactive masses in the pancreas, kidneys, or other organs in cases where the diagnosis of IgG4-RD may not have occurred until after histopathologic analysis was performed. However, these modalities have had some role in treating patients with specific involvements, such as infiltrative masses of tubular structures, such as the biliary tract, lymphadenopathy, or masses in other solid organs. In the recent systematic review of treatment of IgG4-related disease, out of 1,952 patients, 1,437 (74%) were treated with glucocorticoids as first-line, but 213 patients (11%) were treated with surgery or radiotherapy and 38 (2%) were treated with other options<sup><a href="#ref-45">45</a></sup>. Surgery was considered effective in 14 out of 17 patients (82%), and radiation was considered effective in 9 out of 12 patients (75%)<sup><a href="#ref-45">45</a></sup>. Combination surgery and glucocorticoids were effective in 20 out of 22 patients (91%)<sup><a href="#ref-45">45</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1653>Mortality</h2><p class="" id=d21037e1656>In a recent systematic review of treatment of IgG4-related disease, Brito-Zeron <i>et al</i>. compiled the mortality data from 7 studies for 294 patients and a mean follow-up of 29.2 months<sup><a href="#ref-45">45</a></sup>. In this group, mortality was reported in 26 patients (8.8%). Four patients died of pulmonary disease, 1 died of an aneurysm, 1 of cholangitis, 1 of renal failure, 7 of cancer, 4 of cardiovascular disease, 3 of infection, and 5 of unknown or other causes<sup><a href="#ref-45">45</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1673>Pathophysiology of IgG4</h2><div class=section><a name=d21037e1676 class=n-a></a><h3 class=section-title>IgG4 molecule</h3><p class="" id=d21037e1681>The immunoglobulin IgG4 isotype accounts for less than 5% of the total IgG in healthy patients and is the least abundant of the IgG subclasses<sup><a href="#ref-48">48</a></sup>. It is unique among the immunoglobulin isotypes in that it undergoes a process known as fragment antigen-binding (Fab)-arm exchange. The disulfide bonds between the heavy chains of the IgG4 molecules are unstable, so dissociation of the heavy chains occurs, leading to random recombination. The result is antibodies with two different antigen-binding specificities that are unable to cross-link antigen or form immune complexes in a manner similar to that of IgG1, IgG2, and IgG3 antibodies. IgG4 antibodies are also unable to fix complement<sup><a href="#ref-42">42</a>,<a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. IgG4 has traditionally been regarded as anti-inflammatory.</p><p class="" id=d21037e1698>Another unique property of IgG4 is that it sometimes binds the Fc region of IgG, producing a rheumatoid factor (RF), but the physiologic relevance of this is unclear<sup><a href="#ref-50">50</a></sup>. RF was reported to be positive in 20% of patients (50 out of 255) with IgG4-related disease<sup><a href="#ref-6">6</a></sup>. The question of whether IgG4 itself is pathogenic remains to be fully elucidated. Shiokawa <i>et al</i>. injected Balb/c mice with IgGs from patients with IgG4-related disease in order to explore this question<sup><a href="#ref-51">51</a></sup>. Pancreatic injury was seen with both IgG1 and IgG4, but more so from IgG1. Interestingly, patient IgG1-induced damage to the mouse pancreas was somewhat attenuated with the addition of patient IgG4.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1720>Genetics</h2><p class="" id=d21037e1723>There is much still to be learned about the genes involved in IgG4-related disease. Genetic susceptibility has been associated with certain human leukocyte antigen (HLA) haplotypes in Japanese and Korean populations<sup><a href="#ref-49">49</a></sup>. More recent studies have identified genes involved in pancreatic cell injury<sup><a href="#ref-52">52</a></sup>, and cytotoxic T-lymphocyte antigen 4 (CTLA-4) gene polymorphisms have been associated with IgG4-related disease in the pancreas<sup><a href="#ref-53">53</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1741>Autoimmunity</h2><p class="" id=d21037e1744>Autoimmunity has long been hypothesized as a pathologic mechanism in IgG4-related disease, but studies have failed to identify a clear autoantigen specific to the disease that selectively induces the production of IgG4 autoantibodies<sup><a href="#ref-49">49</a></sup>. It stands to reason that the target of the antibody would be specific to the organs commonly affected in IgG4-related disease. Indeed, a recent study which sought to identify autoantigens in IgG4-related disease identified only one candidate: prohibitin<sup><a href="#ref-54">54</a></sup>. As prohibitin is involved in anti-proliferation, the authors hypothesize that antibodies against prohibitin would result in tissue growth and the presentation of IgG4-related disease<sup><a href="#ref-54">54</a></sup>. Another recent study showed that anti-nuclear antibody (ANA) in IgG4-related disease was not of the IgG4 subclass<sup><a href="#ref-55">55</a></sup>. ANA was reported to be positive in 32% of patients (168 out of 524 patients)<sup><a href="#ref-6">6</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1770>Innate immunity</h2><p class="" id=d21037e1773>Evidence is beginning to accumulate that there is a role for innate immunity in the mechanism of IgG4-related disease. Nakajima <i>et al</i>. used DNA microarray analysis to show that the expression of genes associated with allergy or innate immunity is lower in the peripheral blood mononuclear cells of patients with IgG4-related disease compared with healthy controls (HCs) and that these levels were increased with steroid therapy<sup><a href="#ref-56">56</a></sup>. Furthermore, Watanabe <i>et al</i>. recently postulated that since activation of the innate immune system leads to the production of IgG4, this pathway could be the target of future treatments for IgG4-related disease<sup><a href="#ref-57">57</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1794>Hypocomplementemia</h2><p class="" id=d21037e1797>A feature that is important in IgG4-related disease is hypocomplementemia. The etiology of this was studied by Sugimoto <i>et al</i>., who showed that patients with hypocomplementemia in IgG4-related disease have a high serum level of C1q-binding IgG4, thus implying that IgG4 participates in the activation of complement in these patients by an unknown mechanism<sup><a href="#ref-58">58</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1810>Role of T cells (Th2, Treg, Tfh, and CD4<sup>+</sup> CTL)</h2><p class="" id=d21037e1816>It has been observed that CD4 T cells are present at the sites of inflammation in IgG4-related disease. Similar to IgE, class switching to IgG4 depends on interleukin-4 (IL-4) and IL-13. These interleukins are considered part of the type 2 helper T (Th2) immune response. Messenger RNA levels of these Th2 cytokines are higher in organs affected by IgG4-related disease in comparison with other classic autoimmune conditions<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. The peripheral blood lymphocytes of patients with IgG4-related disease also express elevated levels of Th2 cytokines<sup><a href="#ref-60">60</a></sup>. A subset of patients also has elevated eosinophils and IgE, suggestive of an underlying disease mediated by Th2 cytokines.</p><p class="" id=d21037e1830>Allergens and nematodes that induce IgE also induce IgG4. However, a so-called “modified Th2 response” refers to the scenario in which IgG4 antibody is produced without IgE antibody production, which seems to be the desired, healthy response to innocuous antigens, as it occurs during occupational exposures to antigens such as in beekeepers<sup><a href="#ref-48">48</a></sup>. Allergen-specific IgG4 antibodies are also induced during allergen immunotherapy and accompany clinical improvement<sup><a href="#ref-61">61</a></sup>.</p><p class="" id=d21037e1841>A role for elevated levels of regulatory T (Treg) cells in IgG4-related disease has also been suggested<sup><a href="#ref-62">62</a></sup>. This is in contrast to most autoimmune conditions, in which a deficiency in Treg cells is present and thought to promote autoimmunity. In IgG4-related disease, it has been hypothesized that collagen deposition occurs through the production of cytokines produced by Th2 and Treg cells and thus that these cells could act synergistically to induce tissue fibrosis, a prominent feature of the disease<sup><a href="#ref-63">63</a></sup>.</p><p class="" id=d21037e1852>Recent studies<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup> suggest that the role of Th2 immune responses in IgG4-related disease may be overstated and may, in fact, be a reflection of atopy, which affects approximately 40%<sup><a href="#ref-66">66</a></sup> of patients with IgG4-related disease, which is similar to the prevalence in the general US population. Instead, evidence is accumulating for a role of CD4-positive cytotoxic T lymphocytes (CTLs). Maehara <i>et al</i>. have shown over-expression of genes associated with CD4-positive CTLs in the salivary glands of patients with IgG4-related disease compared with HCs and compared with patients with Sjögren’s syndrome and chronic sialoadenitis<sup><a href="#ref-65">65</a></sup>. Furthermore, CD4-positive CTLs, which produce IL-1β, transforming growth factor-beta 1 (TGF-β1), and interferon-gamma (IFN-γ), are found in affected tissue. IL-1β and TGF-β1 have been shown to be involved in the pathology of fibrosis<sup><a href="#ref-67">67</a></sup>, an integral feature of IgG4-related disease, thus further strengthening the putative role of CD4-positive CTLs. Finally, rituximab-mediated B-cell depletion results in both clinical improvement of patients’ IgG4-related disease and a decrease in the number of CD4-positive CTLs<sup><a href="#ref-64">64</a></sup>. This new research is exciting, as CD4-positive CTLs may ultimately prove to be the major mechanism of pathogenesis of IgG4-related disease.</p><p class="" id=d21037e1883>The role of circulating follicular helper T (Tfh) cells in IgG4-related disease is an active area of research. Akiyama <i>et al</i>. have published two articles implicating a role for these cells in IgG4-related disease<sup><a href="#ref-68">68</a>,<a href="#ref-69">69</a></sup>. They showed that in patients with untreated IgG4-RD compared with those with primary Sjögren’s syndrome, those with multi-centric Castleman’s disease, and HCs, the number of circulating Tfh2 cells (defined as CD3<sup>+</sup>CD4<sup>+</sup>CD45RA<sup>−</sup>CXCR5<sup>+</sup>CXCR3<sup>−</sup>CCR6<sup>−</sup>) was significantly increased. Furthermore, “activated” Tfh2 cells (defined by the additional markers CCR7<sup>low</sup>PD-1<sup>high</sup>) were shown to induce IgG4 production and to decrease in response to treatment with glucocorticoids in parallel with decreased disease activity<sup><a href="#ref-68">68</a></sup>. Activated circulating Tfh1 cells were also found to correlate with disease activity but not with serum IgG4 levels<sup><a href="#ref-68">68</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1933>Pathogenic effects of B cells and IgG4</h2><p class="" id=d21037e1936>Maillette de Buy Wenniger <i>et al</i>. showed that IgG4-positive B cells were clonally expanded in patients with IgG4-associated cholangitis and decreased when the patients were treated with glucocorticoids<sup><a href="#ref-70">70</a></sup>. The role of the B cells in IgG4-related disease is especially interesting given the utility of rituximab-mediated CD20<sup>+</sup> B-cell depletion in treating these patients<sup><a href="#ref-46">46</a></sup>. Recent studies have shown that circulating plasmablasts are increased in patients with IgG4-related disease and that their levels reflect disease activity<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. The plasmablasts are oligoclonal, which suggests that specific antigen(s) may be driving their production<sup><a href="#ref-30">30</a></sup>. In B-cell development, plasmablast differentiation occurs between activated B cells and plasma cells.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1968>Role of M2 macrophages and MARCO</h2><p class="" id=d21037e1971>Returning to the issue of the IgG4-related disease being mainly a Th2-mediated disease, a possible disease mechanism could be mediated by M2 macrophages, which are defined as alternatively activated macrophages stimulated by Th2 response. IL-10, IL-13, and CCL18 produced by M2 macrophages induce fibrosis, and a recent study<sup><a href="#ref-71">71</a></sup> showed that there are increased numbers of M2 macrophages in submandibular glands affected by IgG4-related dacryoadenitis and sialoadenitis and that fibrosis is associated with an increased number of M2 macrophages. Macrophage receptor with collagenous structure (MARCO) is a pattern-recognition receptor with an expression pattern similar to that of the M2 macrophage marker CD163. It has been speculated that MARCO may be involved in the initiation of IgG4-related disease<sup><a href="#ref-72">72</a></sup>. Future research is needed to ascertain whether there is any interaction between CD4-positive CTL or Th2 Tfh cells and M2 macrophages in promoting IgG4-related disease.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21037e1985>Conclusions</h2><p class="" id=d21037e1988>IgG4-related disease, though uncommon, is an important disease entity to consider in the differential of a patient presenting with tumefactive lesions. Current research into the underlying pathophysiology is focused on improved understanding of the T-cell and B-cell compartments. Future studies to improve the prognosis of this condition will focus not only on arresting the abnormal immunologic response but also on treating fibrosis.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d21037e1 class=n-a></a><h2 class=main-title id=d21310>Competing interests</h2><p class=metadata-entry><a name=d21037e78 class=n-a></a><p id=d21037e80> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d21037e1 class=n-a></a><h2 class=main-title id=d21312>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d21037e1995 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d21565>References</h2><div class="section ref-list"><a name=d21037e1995 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725412305"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2002 class=n-a></a>Kanno A, Masamune A, Okazaki K, <i> et al.</i>: Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. <i>Pancreas.</i> 2015; <b>44</b>(4): 535–9. <a target=xrefwindow id=d21037e2013 href="http://www.ncbi.nlm.nih.gov/pubmed/25815647">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2016 href="http://dx.doi.org/10.1097/MPA.0000000000000325">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725412305">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725440564"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2029 class=n-a></a>Inoue D, Yoshida K, Yoneda N, <i> et al.</i>: IgG4-related disease: dataset of 235 consecutive patients. <i>Medicine (Baltimore).</i> 2015; <b>94</b>(15): e680. <a target=xrefwindow id=d21037e2040 href="http://www.ncbi.nlm.nih.gov/pubmed/25881845">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2043 href="http://dx.doi.org/10.1097/MD.0000000000000680">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2047 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4602507">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725440564">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d21037e2060 class=n-a></a>Fernández-Codina A, Martínez-Valle F, Pinilla B, <i> et al.</i>: IgG4-Related Disease: Results From a Multicenter Spanish Registry. <i>Medicine (Baltimore).</i> 2015; <b>94</b>(32): e1275. <a target=xrefwindow id=d21037e2071 href="http://www.ncbi.nlm.nih.gov/pubmed/26266361">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2074 href="http://dx.doi.org/10.1097/MD.0000000000001275">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2078 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4616706">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726257560"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2087 class=n-a></a>Karim F, Loeffen J, Bramer W, <i> et al.</i>: IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. <i>Pediatr Rheumatol Online J.</i> 2016; <b>14</b>(1): 18. <a target=xrefwindow id=d21037e2098 href="http://www.ncbi.nlm.nih.gov/pubmed/27012661">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2101 href="http://dx.doi.org/10.1186/s12969-016-0079-3">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2105 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4807566">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726257560">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d21037e2118 class=n-a></a>de Buy Wenniger LJ, Culver EL, Beuers U: Exposure to occupational antigens might predispose to IgG4-related disease. <i>Hepatology.</i> 2014; <b>60</b>(4): 1453–4. <a target=xrefwindow id=d21037e2126 href="http://www.ncbi.nlm.nih.gov/pubmed/24407836">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2129 href="http://dx.doi.org/10.1002/hep.26999">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2132 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4258085">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d21037e2142 class=n-a></a>Stone JH, Brito-Zerón P, Bosch X, <i> et al.</i>: Diagnostic Approach to the Complexity of IgG4-Related Disease. <i>Mayo Clin Proc.</i> 2015; <b>90</b>(7): 927–39. <a target=xrefwindow id=d21037e2153 href="http://www.ncbi.nlm.nih.gov/pubmed/26141331">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2156 href="http://dx.doi.org/10.1016/j.mayocp.2015.03.020">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726639090"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2165 class=n-a></a>Chen Y, Zhao J, Feng R, <i> et al.</i>: Types of Organ Involvement in Patients with Immunoglobulin G4-related Disease. <i>Chin Med J (Engl).</i> 2016; <b>129</b>(13): 1525–32. <a target=xrefwindow id=d21037e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/27364787">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2179 href="http://dx.doi.org/10.4103/0366-6999.184459">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2183 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4931257">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726639090">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725264249"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2196 class=n-a></a>Campbell SN, Rubio E, Loschner AL: Clinical review of pulmonary manifestations of IgG4-related disease. <i>Ann Am Thorac Soc.</i> 2014; <b>11</b>(9): 1466–75. <a target=xrefwindow id=d21037e2204 href="http://www.ncbi.nlm.nih.gov/pubmed/25422997">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2207 href="http://dx.doi.org/10.1513/AnnalsATS.201403-128FR">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725264249">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726273594"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2220 class=n-a></a>Chen BN: IgG4-related disease presenting with destructive sinonasal lesion mimicking malignancy. <i>Eur Arch Otorhinolaryngol.</i> 2016; <b>273</b>(11): 4027–9. <a target=xrefwindow id=d21037e2228 href="http://www.ncbi.nlm.nih.gov/pubmed/27056197">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2231 href="http://dx.doi.org/10.1007/s00405-016-4033-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726273594">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d21037e2244 class=n-a></a>Song BH, Baiyee D, Liang J: A rare and emerging entity: Sinonasal IgG4-related sclerosing disease. <i>Allergy Rhinol (Providence).</i> 2015; <b>6</b>(3): 151–7. <a target=xrefwindow id=d21037e2252 href="http://www.ncbi.nlm.nih.gov/pubmed/26686205">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2255 href="http://dx.doi.org/10.2500/ar.2015.6.0136">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d21037e2264 class=n-a></a>Inoue A, Wada K, Matsuura K, <i> et al.</i>: IgG4-related disease in the sinonasal cavity accompanied by intranasal structure loss. <i>Auris Nasus Larynx.</i> 2016; <b>43</b>(1): 100–4. <a target=xrefwindow id=d21037e2275 href="http://www.ncbi.nlm.nih.gov/pubmed/26104224">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2278 href="http://dx.doi.org/10.1016/j.anl.2015.05.005">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d21037e2288 class=n-a></a>Oh JH, Lee TH, Kim HS, <i> et al.</i>: Esophageal Involvement of Immunoglobulin G4-Related Disease: A Case Report and Literature Review. <i>Medicine (Baltimore).</i> 2015; <b>94</b>(50): e2122. <a target=xrefwindow id=d21037e2299 href="http://www.ncbi.nlm.nih.gov/pubmed/26683918">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2302 href="http://dx.doi.org/10.1097/MD.0000000000002122">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2306 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5058890">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d21037e2315 class=n-a></a>Li D, Kan Y, Fu F, <i> et al.</i>: IgG4-related prostatitis progressed from localized IgG4-related lymphadenopathy. <i>Int J Clin Exp Pathol.</i> 2015; <b>8</b>(9): 11747–52. <a target=xrefwindow id=d21037e2326 href="http://www.ncbi.nlm.nih.gov/pubmed/26617921">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2329 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4637737">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d21037e2338 class=n-a></a>de Buy Wenniger LM, Scheltema JM, Verheij J, <i> et al.</i>: Testicular inflammation as a new manifestation of IgG4-associated disease. <i>Urology.</i> 2013; <b>82</b>(2): e15–6. <a target=xrefwindow id=d21037e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/23896119">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2352 href="http://dx.doi.org/10.1016/j.urology.2013.04.046">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d21037e2361 class=n-a></a>Charrow A, Imadojemu S, Stephen S, <i> et al.</i>: Cutaneous manifestations of IgG4-related disease (RD): A systematic review. <i>J Am Acad Dermatol.</i> 2016; <b>75</b>(1): 197–202. <a target=xrefwindow id=d21037e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/26946983">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2375 href="http://dx.doi.org/10.1016/j.jaad.2016.01.046">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d21037e2384 class=n-a></a>Higashioka K, Yoshida K, Oryoji K, <i> et al.</i>: A Case of Immunoglobulin G4-Related Disease with Extensive Multiorgan Involvements. <i>Case Rep Rheumatol.</i> 2015; <b>2015</b>: 392893. <a target=xrefwindow id=d21037e2395 href="http://www.ncbi.nlm.nih.gov/pubmed/26101684">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2398 href="http://dx.doi.org/10.1155/2015/392893">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2402 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4460202">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1099450"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2411 class=n-a></a>Ghazale A, Chari ST, Zhang L, <i> et al.</i>: Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. <i>Gastroenterology.</i> 2008; <b>134</b>(3): 706–15. <a target=xrefwindow id=d21037e2422 href="http://www.ncbi.nlm.nih.gov/pubmed/18222442">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2425 href="http://dx.doi.org/10.1053/j.gastro.2007.12.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1099450">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d21037e2439 class=n-a></a>Park HG, Kim KM: IgG4-related inflammatory pseudotumor of the renal pelvis involving renal parenchyma, mimicking malignancy. <i>Diagn Pathol.</i> 2016; <b>11</b>: 12. <a target=xrefwindow id=d21037e2447 href="http://www.ncbi.nlm.nih.gov/pubmed/26796327">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2450 href="http://dx.doi.org/10.1186/s13000-016-0460-z">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2453 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4722666">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d21037e2462 class=n-a></a>Wang Y, Chen X, Luo R, <i> et al.</i>: IgG4-related systemic disease mimicking renal pelvic cancer: a rare case. <i>World J Surg Oncol.</i> 2014; <b>12</b>: 395. <a target=xrefwindow id=d21037e2473 href="http://www.ncbi.nlm.nih.gov/pubmed/25539994">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2476 href="http://dx.doi.org/10.1186/1477-7819-12-395">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2480 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4364580">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d21037e2489 class=n-a></a>Kim S, Bae H, Choi M, <i> et al.</i>: Isolated Mass-Forming IgG4-Related Cholangitis as an Initial Clinical Presentation of Systemic IgG4-Related Disease. <i>J Pathol Transl Med.</i> 2016; <b>50</b>(4): 300–5. <a target=xrefwindow id=d21037e2500 href="http://www.ncbi.nlm.nih.gov/pubmed/26755360">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2503 href="http://dx.doi.org/10.4132/jptm.2015.12.01">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2507 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4963967">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d21037e2516 class=n-a></a>Liu Y, Xue F, Yang J, <i> et al.</i>: Immunoglobulin G4-related disease mimicking lymphoma in a Chinese patient. <i>Rheumatol Int.</i> 2015; <b>35</b>(10): 1749–52. <a target=xrefwindow id=d21037e2527 href="http://www.ncbi.nlm.nih.gov/pubmed/25800963">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2530 href="http://dx.doi.org/10.1007/s00296-015-3259-4">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d21037e2539 class=n-a></a>Hiyoshi Y, Oki E, Zaitsu Y, <i> et al.</i>: IgG4-related disease of the ileocecal region mimicking malignancy: A case report. <i>Int J Surg Case Rep.</i> 2014; <b>5</b>(10): 669–72. <a target=xrefwindow id=d21037e2550 href="http://www.ncbi.nlm.nih.gov/pubmed/25194601">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2553 href="http://dx.doi.org/10.1016/j.ijscr.2014.08.003">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4189076">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d21037e2566 class=n-a></a>Sah RP, Chari ST: Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. <i>Curr Opin Rheumatol.</i> 2011; <b>23</b>(1): 108–13. <a target=xrefwindow id=d21037e2574 href="http://www.ncbi.nlm.nih.gov/pubmed/21124093">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2577 href="http://dx.doi.org/10.1097/BOR.0b013e3283413469">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d21037e2587 class=n-a></a>Oseini AM, Chaiteerakij R, Shire AM, <i> et al.</i>: Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. <i>Hepatology.</i> 2011; <b>54</b>(3): 940–8. <a target=xrefwindow id=d21037e2598 href="http://www.ncbi.nlm.nih.gov/pubmed/21674559">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2601 href="http://dx.doi.org/10.1002/hep.24487">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2605 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3253343">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718318678"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2614 class=n-a></a>Carruthers MN, Khosroshahi A, Augustin T, <i> et al.</i>: The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(1): 14–8. <a target=xrefwindow id=d21037e2625 href="http://www.ncbi.nlm.nih.gov/pubmed/24651618">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2628 href="http://dx.doi.org/10.1136/annrheumdis-2013-204907">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718318678">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d21037e2641 class=n-a></a>Ghazale A, Chari ST, Smyrk TC, <i> et al.</i>: Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. <i>Am J Gastroenterol.</i> 2007; <b>102</b>(8): 1646–53. <a target=xrefwindow id=d21037e2652 href="http://www.ncbi.nlm.nih.gov/pubmed/17555461">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2655 href="http://dx.doi.org/10.1111/j.1572-0241.2007.01264.x">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d21037e2664 class=n-a></a>Boonstra K, Culver EL, de Buy Wenniger LM, <i> et al.</i>: Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. <i>Hepatology.</i> 2014; <b>59</b>(5): 1954–63. <a target=xrefwindow id=d21037e2675 href="http://www.ncbi.nlm.nih.gov/pubmed/24375491">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2678 href="http://dx.doi.org/10.1002/hep.26977">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2682 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4489327">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d21037e2691 class=n-a></a>Mendes FD, Jorgensen R, Keach J, <i> et al.</i>: Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. <i>Am J Gastroenterol.</i> 2006; <b>101</b>(9): 2070–5. <a target=xrefwindow id=d21037e2702 href="http://www.ncbi.nlm.nih.gov/pubmed/16879434">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2705 href="http://dx.doi.org/10.1111/j.1572-0241.2006.00772.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d21037e2714 class=n-a></a>Kamisawa T, Shimosegawa T, Okazaki K, <i> et al.</i>: Standard steroid treatment for autoimmune pancreatitis. <i>Gut.</i> 2009; <b>58</b>(11): 1504–7. <a target=xrefwindow id=d21037e2725 href="http://www.ncbi.nlm.nih.gov/pubmed/19398440">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2728 href="http://dx.doi.org/10.1136/gut.2008.172908">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d21037e2738 class=n-a></a>Mattoo H, Mahajan VS, Della-Torre E, <i> et al.</i>: <i>De novo</i> oligoclonal expansions of circulating plasmablasts in active and relapsing IgG<sub>4</sub>-related disease. <i>J Allergy Clin Immunol.</i> 2014; <b>134</b>(3): 679–87. <a target=xrefwindow id=d21037e2756 href="http://www.ncbi.nlm.nih.gov/pubmed/24815737">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2759 href="http://dx.doi.org/10.1016/j.jaci.2014.03.034">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2762 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4149918">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718382227"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2771 class=n-a></a>Wallace ZS, Mattoo H, Carruthers M, <i> et al.</i>: Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(1): 190–5. <a target=xrefwindow id=d21037e2782 href="http://www.ncbi.nlm.nih.gov/pubmed/24817416">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2785 href="http://dx.doi.org/10.1136/annrheumdis-2014-205233">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2789 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4656194">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718382227">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726236661"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e2802 class=n-a></a>Doorenspleet ME, Hubers LM, Culver EL, <i> et al.</i>: Immunoglobulin G4<sup>+</sup> B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. <i>Hepatology.</i> 2016; <b>64</b>(2): 501–7. <a target=xrefwindow id=d21037e2816 href="http://www.ncbi.nlm.nih.gov/pubmed/27015613">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2820 href="http://dx.doi.org/10.1002/hep.28568">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2823 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5017301">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726236661">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d21037e2836 class=n-a></a>Khosroshahi A, Cheryk LA, Carruthers MN, <i> et al.</i>: Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(1): 213–7. <a target=xrefwindow id=d21037e2847 href="http://www.ncbi.nlm.nih.gov/pubmed/24431286">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2850 href="http://dx.doi.org/10.1002/art.38193">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d21037e2859 class=n-a></a>Zhang J, Chen H, Ma Y, <i> et al.</i>: Characterizing IgG4-related disease with <sup>18</sup>F-FDG PET/CT: a prospective cohort study. <i>Eur J Nucl Med Mol Imaging.</i> 2014; <b>41</b>(8): 1624–34. <a target=xrefwindow id=d21037e2873 href="http://www.ncbi.nlm.nih.gov/pubmed/24764034">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2877 href="http://dx.doi.org/10.1007/s00259-014-2729-3">Publisher Full Text </a> | <a target=xrefwindow id=d21037e2880 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4089015">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d21037e2889 class=n-a></a>Vaidyanathan S, Patel CN, Scarsbrook AF, <i> et al.</i>: FDG PET/CT in infection and inflammation--current and emerging clinical applications. <i>Clin Radiol.</i> 2015; <b>70</b>(7): 787–800. <a target=xrefwindow id=d21037e2900 href="http://www.ncbi.nlm.nih.gov/pubmed/25917543">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2903 href="http://dx.doi.org/10.1016/j.crad.2015.03.010">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d21037e2913 class=n-a></a>Toyoda K, Oba H, Kutomi K, <i> et al.</i>: MR imaging of IgG4-related disease in the head and neck and brain. <i>AJNR Am J Neuroradiol.</i> 2012; <b>33</b>(11): 2136–9. <a target=xrefwindow id=d21037e2924 href="http://www.ncbi.nlm.nih.gov/pubmed/22700747">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2927 href="http://dx.doi.org/10.3174/ajnr.A3147">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d21037e2936 class=n-a></a>Fujita A, Sakai O, Chapman MN, <i> et al.</i>: IgG4-related disease of the head and neck: CT and MR imaging manifestations. <i>Radiographics.</i> 2012; <b>32</b>(7): 1945–58. <a target=xrefwindow id=d21037e2947 href="http://www.ncbi.nlm.nih.gov/pubmed/23150850">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2950 href="http://dx.doi.org/10.1148/rg.327125032">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d21037e2959 class=n-a></a>Deshpande V, Zen Y, Chan JK, <i> et al.</i>: Consensus statement on the pathology of IgG4-related disease. <i>Mod Pathol.</i> 2012; <b>25</b>(9): 1181–92. <a target=xrefwindow id=d21037e2970 href="http://www.ncbi.nlm.nih.gov/pubmed/22596100">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2973 href="http://dx.doi.org/10.1038/modpathol.2012.72">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d21037e2982 class=n-a></a>Strehl JD, Hartmann A, Agaimy A: Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. <i>J Clin Pathol.</i> 2011; <b>64</b>(3): 237–43. <a target=xrefwindow id=d21037e2990 href="http://www.ncbi.nlm.nih.gov/pubmed/21233087">PubMed Abstract </a> | <a target=xrefwindow id=d21037e2993 href="http://dx.doi.org/10.1136/jcp.2010.085613">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d21037e3002 class=n-a></a>Cheuk W, Chan JK: Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity. <i>Semin Diagn Pathol.</i> 2012; <b>29</b>(4): 226–34. <a target=xrefwindow id=d21037e3010 href="http://www.ncbi.nlm.nih.gov/pubmed/23068302">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3013 href="http://dx.doi.org/10.1053/j.semdp.2012.07.001">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726657496"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3022 class=n-a></a>Masamune A, Nishimori I, Kikuta K, <i> et al.</i>: Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. <i>Gut.</i> 2017; <b>66</b>(3): 487–494. <a target=xrefwindow id=d21037e3033 href="http://www.ncbi.nlm.nih.gov/pubmed/27543430">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3036 href="http://dx.doi.org/10.1136/gutjnl-2016-312049">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726657496">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725266714"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3050 class=n-a></a>Kamisawa T, Zen Y, Pillai S, <i> et al.</i>: IgG4-related disease. <i>Lancet.</i> 2015; <b>385</b>(9976): 1460–71. <a target=xrefwindow id=d21037e3061 href="http://www.ncbi.nlm.nih.gov/pubmed/25481618">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3064 href="http://dx.doi.org/10.1016/S0140-6736(14)60720-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725266714">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d21037e3077 class=n-a></a>Kamisawa T, Okazaki K, Kawa S, <i> et al.</i>: Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. <i>J Gastroenterol.</i> 2010; <b>45</b>(5): 471–7. <a target=xrefwindow id=d21037e3088 href="http://www.ncbi.nlm.nih.gov/pubmed/20213336">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3091 href="http://dx.doi.org/10.1007/s00535-010-0221-9">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d21037e3100 class=n-a></a>Buijs J, van Heerde MJ, Rauws EA, <i> et al.</i>: Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis. <i>Pancreas.</i> 2014; <b>43</b>(2): 261–7. <a target=xrefwindow id=d21037e3111 href="http://www.ncbi.nlm.nih.gov/pubmed/24518506">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3114 href="http://dx.doi.org/10.1097/MPA.0000000000000044">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303228"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3123 class=n-a></a>Brito-Zerón P, Kostov B, Bosch X, <i> et al.</i>: Therapeutic approach to IgG4-related disease: A systematic review. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(26): e4002. <a target=xrefwindow id=d21037e3134 href="http://www.ncbi.nlm.nih.gov/pubmed/27368010">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3137 href="http://dx.doi.org/10.1097/MD.0000000000004002">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3141 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4937924">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303228">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725346830"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3154 class=n-a></a>Carruthers MN, Topazian MD, Khosroshahi A, <i> et al.</i>: Rituximab for IgG4-related disease: a prospective, open-label trial. <i>Ann Rheum Dis.</i> 2015; <b>74</b>(6): 1171–7. <a target=xrefwindow id=d21037e3165 href="http://www.ncbi.nlm.nih.gov/pubmed/25667206">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3168 href="http://dx.doi.org/10.1136/annrheumdis-2014-206605">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725346830">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303229"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3181 class=n-a></a>Yamamoto M, Takahashi H, Takano K, <i> et al.</i>: Efficacy of abatacept for IgG4-related disease over 8 months. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(8): 1576–8. <a target=xrefwindow id=d21037e3192 href="http://www.ncbi.nlm.nih.gov/pubmed/27147710">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3195 href="http://dx.doi.org/10.1136/annrheumdis-2016-209368">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303229">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d21037e3209 class=n-a></a>Aalberse RC, Stapel SO, Schuurman J, <i> et al.</i>: Immunoglobulin G4: an odd antibody. <i>Clin Exp Allergy.</i> 2009; <b>39</b>(4): 469–77. <a target=xrefwindow id=d21037e3220 href="http://www.ncbi.nlm.nih.gov/pubmed/19222496">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3223 href="http://dx.doi.org/10.1111/j.1365-2222.2009.03207.x">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d21037e3232 class=n-a></a>Stone JH, Zen Y, Deshpande V: IgG4-related disease. <i>N Engl J Med.</i> 2012; <b>366</b>(6): 539–51. <a target=xrefwindow id=d21037e3240 href="http://www.ncbi.nlm.nih.gov/pubmed/22316447">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3243 href="http://dx.doi.org/10.1056/NEJMra1104650">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d21037e3252 class=n-a></a>Kawa S, Kitahara K, Hamano H, <i> et al.</i>: A novel immunoglobulin-immunoglobulin interaction in autoimmunity. <i>PLoS One.</i> 2008; <b>3</b>(2): e1637. <a target=xrefwindow id=d21037e3263 href="http://www.ncbi.nlm.nih.gov/pubmed/18297131">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3266 href="http://dx.doi.org/10.1371/journal.pone.0001637">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3270 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2249926">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726211869"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3279 class=n-a></a>Shiokawa M, Kodama Y, Kuriyama K, <i> et al.</i>: Pathogenicity of IgG in patients with IgG4-related disease. <i>Gut.</i> 2016; <b>65</b>(8): 1322–32. <a target=xrefwindow id=d21037e3290 href="http://www.ncbi.nlm.nih.gov/pubmed/26964842">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3293 href="http://dx.doi.org/10.1136/gutjnl-2015-310336">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726211869">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d21037e3306 class=n-a></a>Chang MC, Jan IS, Liang PC, <i> et al.</i>: Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis. <i>J Gastroenterol Hepatol.</i> 2014; <b>29</b>(12): 2038–42. <a target=xrefwindow id=d21037e3317 href="http://www.ncbi.nlm.nih.gov/pubmed/24909264">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3320 href="http://dx.doi.org/10.1111/jgh.12649">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d21037e3329 class=n-a></a>Chang MC, Chang YT, Tien YW, <i> et al.</i>: T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. <i>Clin Chem.</i> 2007; <b>53</b>(9): 1700–5. <a target=xrefwindow id=d21037e3340 href="http://www.ncbi.nlm.nih.gov/pubmed/17712006">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3343 href="http://dx.doi.org/10.1373/clinchem.2007.085951">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725457482"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3353 class=n-a></a>Du H, Shi L, Chen P, <i> et al.</i>: Prohibitin Is Involved in Patients with IgG4 Related Disease. <i>PLoS One.</i> 2015; <b>10</b>(5): e0125331. <a target=xrefwindow id=d21037e3364 href="http://www.ncbi.nlm.nih.gov/pubmed/25932630">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3367 href="http://dx.doi.org/10.1371/journal.pone.0125331">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3371 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4416882">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725457482">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725522461"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3384 class=n-a></a>Kiyama K, Yoshifuji H, Kandou T, <i> et al.</i>: Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. <i>BMC Musculoskelet Disord.</i> 2015; <b>16</b>: 129. <a target=xrefwindow id=d21037e3395 href="http://www.ncbi.nlm.nih.gov/pubmed/26018403">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3398 href="http://dx.doi.org/10.1186/s12891-015-0584-4">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3402 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4447006">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725522461">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725495635"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3415 class=n-a></a>Nakajima A, Masaki Y, Nakamura T, <i> et al.</i>: Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease. <i>PLoS One.</i> 2015; <b>10</b>(5): e0126582. <a target=xrefwindow id=d21037e3426 href="http://www.ncbi.nlm.nih.gov/pubmed/25973893">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3429 href="http://dx.doi.org/10.1371/journal.pone.0126582">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3433 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4431830">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725495635">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727303233"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3446 class=n-a></a>Watanabe T, Yamashita K, Kudo M: IgG4-Related Disease and Innate Immunity. <i>Curr Top Microbiol Immunol.</i> 2016. <a target=xrefwindow id=d21037e3451 href="http://www.ncbi.nlm.nih.gov/pubmed/27744509">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3454 href="http://dx.doi.org/10.1007/82_2016_42">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727303233">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725781424"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3467 class=n-a></a>Sugimoto M, Watanabe H, Asano T, <i> et al.</i>: Possible participation of IgG4 in the activation of complement in IgG4-related disease with hypocomplementemia. <i>Mod Rheumatol.</i> 2016; <b>26</b>(2): 251–8. <a target=xrefwindow id=d21037e3478 href="http://www.ncbi.nlm.nih.gov/pubmed/26357950">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3481 href="http://dx.doi.org/10.3109/14397595.2015.1076924">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725781424">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d21037e3494 class=n-a></a>Zen Y, Fujii T, Harada K, <i> et al.</i>: Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. <i>Hepatology.</i> 2007; <b>45</b>(6): 1538–46. <a target=xrefwindow id=d21037e3505 href="http://www.ncbi.nlm.nih.gov/pubmed/17518371">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3508 href="http://dx.doi.org/10.1002/hep.21697">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d21037e3518 class=n-a></a>Miyake K, Moriyama M, Aizawa K, <i> et al.</i>: Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. <i>Mod Rheumatol.</i> 2008; <b>18</b>(1): 86–90. <a target=xrefwindow id=d21037e3529 href="http://www.ncbi.nlm.nih.gov/pubmed/18094933">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3532 href="http://dx.doi.org/10.1007/s10165-007-0010-3">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d21037e3541 class=n-a></a>Akdis M, Akdis CA: Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. <i>J Allergy Clin Immunol.</i> 2014; <b>133</b>(3): 621–31. <a target=xrefwindow id=d21037e3549 href="http://www.ncbi.nlm.nih.gov/pubmed/24581429">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3552 href="http://dx.doi.org/10.1016/j.jaci.2013.12.1088">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726552841"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3561 class=n-a></a>Zen Y, Kawakami H, Kim JH: IgG4-related sclerosing cholangitis: all we need to know. <i>J Gastroenterol.</i> 2016; <b>51</b>(4): 295–312. <a target=xrefwindow id=d21037e3569 href="http://www.ncbi.nlm.nih.gov/pubmed/26817943">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3572 href="http://dx.doi.org/10.1007/s00535-016-1163-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726552841">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d21037e3585 class=n-a></a>Della-Torre E, Lanzillotta M, Doglioni C: Immunology of IgG4-related disease. <i>Clin Exp Immunol.</i> 2015; <b>181</b>(2): 191–206. <a target=xrefwindow id=d21037e3593 href="http://www.ncbi.nlm.nih.gov/pubmed/25865251">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3596 href="http://dx.doi.org/10.1111/cei.12641">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3599 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4516435">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726216749"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3608 class=n-a></a>Mattoo H, Mahajan VS, Maehara T, <i> et al.</i>: Clonal expansion of CD4<sup>+</sup> cytotoxic T lymphocytes in patients with IgG<sub>4</sub>-related disease. <i>J Allergy Clin Immunol.</i> 2016; <b>138</b>(3): 825–38. <a target=xrefwindow id=d21037e3626 href="http://www.ncbi.nlm.nih.gov/pubmed/26971690">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3629 href="http://dx.doi.org/10.1016/j.jaci.2015.12.1330">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3632 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5014627">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726216749">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d21037e3645 class=n-a></a>Maehara T, Mattoo H, Ohta M, <i> et al.</i>: Lesional CD4<sup>+</sup> IFN-γ<sup>+</sup> cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(2): 377–85. <a target=xrefwindow id=d21037e3663 href="http://www.ncbi.nlm.nih.gov/pubmed/27358392">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3666 href="http://dx.doi.org/10.1136/annrheumdis-2016-209139">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d21037e3676 class=n-a></a>Della Torre E, Mattoo H, Mahajan VS, <i> et al.</i>: Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. <i>Allergy.</i> 2014; <b>69</b>(2): 269–72. <a target=xrefwindow id=d21037e3687 href="http://www.ncbi.nlm.nih.gov/pubmed/24266692">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3690 href="http://dx.doi.org/10.1111/all.12320">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3694 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4638385">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d21037e3703 class=n-a></a>Wynn TA, Ramalingam TR: Mechanisms of fibrosis: therapeutic translation for fibrotic disease. <i>Nat Med.</i> 2012; <b>18</b>(7): 1028–1040. <a target=xrefwindow id=d21037e3711 href="http://www.ncbi.nlm.nih.gov/pubmed/22772564">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3714 href="http://dx.doi.org/10.1038/nm.2807">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3717 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3405917">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726505895"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3726 class=n-a></a>Akiyama M, Yasuoka H, Yamaoka K, <i> et al.</i>: Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. <i>Arthritis Res Ther.</i> 2016; <b>18</b>: 167. <a target=xrefwindow id=d21037e3737 href="http://www.ncbi.nlm.nih.gov/pubmed/27411315">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3740 href="http://dx.doi.org/10.1186/s13075-016-1064-4">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3744 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4944254">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726505895">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d21037e3757 class=n-a></a>Akiyama M, Suzuki K, Yamaoka K, <i> et al.</i>: Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(9): 2476–81. <a target=xrefwindow id=d21037e3768 href="http://www.ncbi.nlm.nih.gov/pubmed/25989153">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3771 href="http://dx.doi.org/10.1002/art.39209">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d21037e3780 class=n-a></a>Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, <i> et al.</i>: Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. <i>Hepatology.</i> 2013; <b>57</b>(6): 2390–8. <a target=xrefwindow id=d21037e3791 href="http://www.ncbi.nlm.nih.gov/pubmed/23300096">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3794 href="http://dx.doi.org/10.1002/hep.26232">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725293910"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21037e3803 class=n-a></a>Furukawa S, Moriyama M, Tanaka A, <i> et al.</i>: Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. <i>Clin Immunol.</i> 2015; <b>156</b>(1): 9–18. <a target=xrefwindow id=d21037e3814 href="http://www.ncbi.nlm.nih.gov/pubmed/25450336">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3817 href="http://dx.doi.org/10.1016/j.clim.2014.10.008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725293910">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d21037e3831 class=n-a></a>Ohta M, Moriyama M, Maehara T, <i> et al.</i>: DNA Microarray Analysis of Submandibular Glands in IgG4-Related Disease Indicates a Role for MARCO and Other Innate Immune-Related Proteins. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(7): e2853. <a target=xrefwindow id=d21037e3842 href="http://www.ncbi.nlm.nih.gov/pubmed/26886650">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3845 href="http://dx.doi.org/10.1097/MD.0000000000002853">Publisher Full Text </a> | <a target=xrefwindow id=d21037e3849 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4998650">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d21037e3858 class=n-a></a>Chari ST: Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. <i>J Gastroenterol.</i> 2007; <b>42</b>(Suppl 18): 39–41. <a target=xrefwindow id=d21037e3866 href="http://www.ncbi.nlm.nih.gov/pubmed/17520222">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3869 href="http://dx.doi.org/10.1007/s00535-007-2046-8">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d21037e3878 class=n-a></a>Umehara H, Okazaki K, Masaki Y, <i> et al.</i>: Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. <i>Mod Rheumatol.</i> 2012; <b>22</b>(1): 21–30. <a target=xrefwindow id=d21037e3889 href="http://www.ncbi.nlm.nih.gov/pubmed/22218969">PubMed Abstract </a> | <a target=xrefwindow id=d21037e3892 href="http://dx.doi.org/10.1007/s10165-011-0571-z">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Feb 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-185&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-185&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Massachusetts General Hospital, Allergy and Immunology Division, Cox 201, 55 Fruit Street, Boston, Massachusetts, 02114, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-185/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 23 Feb 2017, 6:185 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.9399.1">https://doi.org/10.12688/f1000research.9399.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Wolfson AR and Hamilos DL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=10123 data-id=9399 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9399.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-185/v1/pdf?article_uuid=ef29d428-3655-46c9-8aab-e7ae66c36d01" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.9399.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Wolfson AR and Hamilos DL. Recent advances in understanding and managing IgG4-related disease [version 1; peer review: 4 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):185 (<a href="https://doi.org/10.12688/f1000research.9399.1" target=_blank>https://doi.org/10.12688/f1000research.9399.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=9399 id=mobile-track-article-signin-9399 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9399?target=/articles/6-185"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10123 /> <input name=articleId type=hidden value=9399 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Motohisa Yamamoto</strong>, Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Tsutomu Takeuchi</strong>, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Rohit K. Katial</strong>, National Jewish Health, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Mitsuhiro Kawano</strong>, Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Japan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Feb 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-185&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-185&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=20016-19680></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=20019-19683></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=20018-19682></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=20017-19681></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-185/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>23 Feb 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Motohisa Yamamoto</strong>, Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Tsutomu Takeuchi</strong>, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Rohit K. Katial</strong>, National Jewish Health, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Mitsuhiro Kawano</strong>, Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Japan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-185&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-185/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-185/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-185/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-185/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Wolfson AR and Hamilos DL');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-185/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-185",
            templates : {
                twitter : "Recent advances in understanding and managing IgG4-related disease. Wolfson AR and Hamilos DL, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-185/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and managing IgG4-related disease", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and managing IgG4-related disease", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/9399/10123")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "10123");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "19680": 0,
                           "19681": 0,
                           "19682": 0,
                           "19683": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "748123cd-e9e6-4434-ad7a-25885bd2019d";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-185.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-185.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-185.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-185.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-185.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>